Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tianye Zhao has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Jiang

    Meihe Health Research Institute The First Hospital of Jilin University Changchun China

    2 shared publications
  • Yangyu Zhang

    Department of Clinical Epidemiology the First Hospital of Jilin University Changchun China

    2 shared publications
  • Changgui Kou

    Department of Epidemiology and Biostatistics, School of Public Health Jilin University Changchun China

    1 shared publication
  • Donghui Cao

    Department of Clinical Epidemiology the First Hospital of Jilin University Changchun China

    1 shared publication
  • Haiyong Lv

    Department of Clinical Epidemiology the First Hospital of Jilin University Changchun China

    1 shared publication
  • Hongqin Xu

    Department of Hepatology The First Hospital of Jilin University Changchun China

    1 shared publication

Latest Publications

  • Open Access

    Risk‐stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10‐year follow‐up

    by Hua He, Yanhua Wu, Zhifang Jia, Hongqin Xu, Yuchen Pan, Donghui Cao, Yangyu Zhang, Xuerong Tao, Tianye Zhao, Haiyong Lv, et al.

    The aim of this study was to determine whether the age-Male-ALBI-Platelet (aMAP) score is applicable in community settings and how to maximise its role in risk stratification. A total of thousand five hundred and three participants had an aMAP score calculated at baseline and were followed up for about 10 years to obtain information on liver cancer incidence and death. After assessing the ability of aMAP to predict liver cancer incidence and death in terms of differentiation and calibration, the optimal risk stratification threshold of the aMAP score was explored, based on absolute and relative risks. The aMAP score achieved higher area under curves (AUCs) (almost all above 0.8) within 10 years and exhibited a better calibration within 5 years. Regarding absolute risk, the risk of incidence of and death from liver cancer showed a rapid increase after an aMAP score of 55. The cumulative incidence (5- year: 8.3% vs. 1.3% and 10- year: 20.9% vs. 3.6%) and mortality (5- year: 6.7% vs. 1.1% and 10-year: 17.5% vs. 3.1%) of liver cancer in individuals with an aMAP score of =55 were significantly higher than in those with a score of <55 (Grey's test p < .001). In terms of relative risk, the risk of death from liver cancer surpassed that from other causes after an aMAP score of =55 [HR= 1.38(1.02- 1.87)]. Notably, the two types of death risk had opposite trends between the subpopulation with an aMAP score of =55 and < 55. To conclude, this study showed the value of the aMAP score in community settings and recommends using 55 as a new risk stratification threshold to guide subsequent liver cancer screening.


  • Open Access

    Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis

    by Lili Qin, Yueqi Wang, Na Yang, Yangyu Zhang, Tianye Zhao, Yanhua Wu, Jing Jiang

    Background Tissue inhibitor of metalloproteinase 1 (TIMP-1) has recently been shown to be dependent on or independent of Matrix metalloproteinases (MMPs) in its roles in tumorigenesis and progression. This appreciation has prompted various studies assessing the prognostic value of TIMP-1 in patients with gastrointestinal cancer, however, the conclusions were still inconsistent. The aim of this study was to assess the prognostic value of TIMP-1-immunohistochemistry (IHC) staining and pretreatment serum/plasma TIMP-1 level in gastrointestinal cancer survival as well as the association between TIMP-1 and clinicopathologic features. Methods The meta-analysis was registered in the International Prospective Register of Systematic Reviews (PROSPERO; Registration NO. CRD42020185407) and followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. A highly sensitive literature search was performed in electronic databases including PubMed, EMBASE and the Cochrane Library. Heterogeneity analysis was conducted using both chi-square-based Q statistics and the I2 test. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to assess the prognostic value of TIMP-1 using the fixed-effects model. Odds ratios (ORs) with 95% CIs were calculated to evaluate the associations between TIMP-1 and clinicopathological characteristics. The meta-analysis was conducted using STATA 12.0 software. Results A total of 3,958 patients from twenty-two studies were included in the meta-analysis. Elevated TIMP-1 levels were significantly associated with poor survival in gastrointestinal cancer (TIMP-1-IHC staining: HR = 2.04, 95% CI [1.59–2.61], I2 = 35.7%, PQ = 0.156; pretreatment serum/plasma TIMP-1 levels: HR = 2.02, 95% CI [1.80–2.28], I2 = 0%, PQ = 0.630). Moreover, clinicopathological parameter data analysis showed that elevated TIMP-1 levels were significantly associated with lymph node metastasis (N1/N2/N3 vs N0: OR = 2.92, 95% CI [1.95–4.38]) and higher TNM stages (III/IV vs I/II: OR = 2.73, 95% CI [1.23–6.04]). Conclusion Both TIMP-1-positive IHC staining and high serum/plasma TIMP-1 levels are poor prognostic factors for the survival of gastrointestinal cancer. In addition, TIMP-1 overexpression was correlated with more advanced clinicopathological features.


  • An Analysis of Recently Retracted Articles by Authors Affiliated with Hospitals in Mainland China

    by Tianye Zhao, Tiancong Dai, Zhijun Lun, Yanli Gao

    The aim of this study was to analyze the features of retracted articles by authors affiliated with hospitals in mainland China. We searched the PubMed, Web of Science, and Retraction Watch databases for retractions and identified the following characteristics of each retracted article: publisher, open access status, impact factor of the journal that retracted the article, any PubPeer comments recorded before the retraction, status of the hospital where the authors worked, and any response to the retraction from the authors. We found 521 retractions, primarily by authors at grade A, third-level hospitals located in a limited number of regions of mainland China, and found that the journals that had published and later retracted the articles tended to have a medium to high impact factor. The main reasons for retraction were data manipulation, fabrication, or fraud; errors made by the authors; or plagiarism. Few of the retracted publications had PubPeer comments before their retraction. This is the first report to focus on retracted research coming out of hospitals in mainland China. The large number of retractions for Chinese hospitals is worrying. The results suggest that some retractions were related to third parties that provided editorial and other services.


  • Effect of the TYK-2/STAT-3 pathway on lipid accumulation induced by mono-2-ethylhexyl phthalate

    by Wen Qi, Liting Zhou, Tianye Zhao, Shuang Ding, Qi Xu, Xu Han, Yaming Zhao, Xinyue Song, Tianyang Zhao, Xiaohan Zhang, et al.